Regulations are vague regarding the appropriate decision-maker and authority to consent for children of minor parents participating in clinical trials. In countries with high rates of underage mothers, such as in sub-Saharan Africa, this lack of guidance may affect the rights of potential paediatric participants already bearing increased vulnerability. It can also influence the recruitment and generalizability of the research. We provide evidence and discuss informed consent management in such cases to inform best practice.
Materials and methods
We searched PubMed/MEDLINE, Embase, CINAHL, and Google Scholar for articles published up to March 2019. In total, 4382 articles were screened, of which 16 met our inclusion criteria. Studies addressing informed consent in clinical trials involving children with minor parents in sub-Saharan Africa were included. We performed descriptive and qualitative framework analyses. The review was registered in PROSPERO: CRD42018074220.
Various informed consent approaches were reported. Articles supporting individual consent by minor parents based on emancipation or “mature minor” status lacked evidence in the context of research. National laws on medical care guided consent instead. When no laws or guidance existed an interpretation of the local decision-making culture, including community engagement and collaboration with local ethics committees, defined the informed consent approach.
The review emphasises that the implementation of informed consent for children with minor parents may be variable and hampered by absent or ambiguous clinical trial regulations, as well as divergent local realities. It may further be influenced by the research area and study-specific risks. Clear guidance is required to help address these challenges proactively in clinical trial planning. We provided a set of questions to be considered in the development of an ethically acceptable informed consent approach and proposed information that should be integrated into international clinical trial guidelines.
Citation: De Pretto-Lazarova A, Brancati-Badarau DO, Burri C (2020) Informed consent approaches for clinical trial participation of infants with minor parents in sub-Saharan Africa: A systematic review. PLoS ONE 15(8): e0237088. https://doi.org/10.1371/journal.pone.0237088
Editor: Simeon-Pierre Choukem, University of Dschang Faculty of Medicine and Pharmaceutical Sciences, CAMEROON
Received: January 29, 2020; Accepted: July 20, 2020; Published: August 4, 2020
Copyright: © 2020 De Pretto-Lazarova et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: This study was supported by the European and Developing Countries Clinical Trials Partnership (https://www.edctp.org/), the Swiss Tropical and Public Health Institute (https://www.swisstph.ch/en/), and the Freiwillige Akademische Gesellschaft (https://www.fag-basel.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Enrolment of children into clinical trials (CTs) is mandatory to enable the development of new medicines for this population . Infectious diseases and malnutrition remain essential factors affecting childhood mortality, with around 50% of all cases occurring in Africa [2–4]. Compared to Europe or the USA, a higher proportion of CTs conducted in sub-Saharan Africa (SSA) involve children [5, 6]. Adolescent birth rates in SSA countries are also among the highest worldwide , increasing the likelihood that research staff might have to deal with the ethical challenge of obtaining valid informed consent (IC) for infant participation from minor parents.
International guidelines on the conduct of CTs state that by being recognised as "emancipated" or "mature minors" through marriage, parenthood, etc. [1, 8], adolescents may be allowed to consent autonomously. However, it remains unclear whether autonomous consent refers only to adolescent’s own research participation or whether such minors may consent independently for their child as well.
Further specifications regarding the "emancipated" or "mature minors" status are subject to national provisions [1, 8, 9]. In the UK and the USA, professional guidelines recognise that minor parents can be responsible for medical decision-making for their children if they are considered competent. Nevertheless, these guidelines lack strict criteria or principles defining such competence in relation to minor parents and its applicability to clinical trials [10, 11].
In some SSA countries, such as Kenya, guidelines may be in place (e.g., a national CT regulation or institutional guidance for the conduct of CTs) determining whether minor parents may consent for their children [9, 12]. However, such guidance may be missing, unclear, or difficult to source in other SSA countries. Even when concepts for “emancipated” or “mature minors” exist in general national legislations or research specific guidelines, their transferability to the context of CTs and the consent for children of minors often remain unspecified . In addition, social and cultural norms may differ from country to country posing challenges for researchers in the development and implementation of IC procedures [9, 14].
Considerable efforts in the past decades sought to improve quality standards in global paediatric research, including strengthening recommendations on IC practices [15–17]. However, formal international guidance on implementing an ethically acceptable approach to the IC process for children with minor parents in various CT contexts is still lacking. There is a paramount need for best practices on IC, which ensure adequate protection while maintaining the option to enrol children under such circumstances.
The objective of this study was to address this gap by mapping the reported approaches to IC in paediatric CTs involving minor parents in SSA as identified through a systematic literature review.
Materials and methods
We conducted a systematic literature review and searched PubMed/MEDLINE, Embase, CINAHL, and Google Scholar to collect information on IC practices for children with minor parents included in CTs conducted in SSA. We used search terms related to the elements of IC, decision-making, CTs, minors, and SSA (Box 1). Reference lists of included articles were also screened. We performed the initial search in July 2017 (S1 Text) and updated it in March 2019 based on a reviewed search strategy by a medical librarian. The changes applied to the search strategy included: improving the combination structure of registered and free-text terms, removing language filters, removing animal studies, instead of limiting to humans, removing redundancies (term combinations were removed as single terms already covered them), complementing child MeSH and free text terms, as well as adding the terms “research”, “placebo”, and all sub-Saharan African countries. Information on search strategies for all other databases can be found in the appendix (S1 Text). No protocol was published for this review.
Box 1. Search strategy (updated search)
Informed consent AND minors AND decision-making AND clinical trials AND sub-Saharan Africa
("Informed Consent"[Mesh] OR "Parental Notification"[Mesh] OR "Presumed Consent"[Mesh] OR "patient information"[tiab] OR consent[tiab] OR consented[tiab] OR consenting[tiab] OR assent*[tiab] OR parental permission*[tiab])
("Minors"[Mesh] OR "Child"[Mesh] OR "Infant"[Mesh] OR "Adolescent"[Mesh] OR "Child, Orphaned"[Mesh] OR "Pediatrics"[Mesh] OR "Pregnancy in Adolescence"[Mesh] OR "Maternal Age"[Mesh] OR "Vulnerable Populations"[Mesh] OR "Child Health Services"[mh] OR "Hospitals, Pediatric"[mh] OR "Intensive Care Units, Pediatric"[Mesh] OR minor*[tiab] OR pediatr*[tiab] OR paediatr*[tiab] OR child[tiab] OR children[tiab] OR childhood[tiab] OR infant*[tiab] OR newborn*[tiab] OR new born*[tiab] OR baby[tiab] OR babies[tiab] OR neonat*[tiab] OR perinat*[tiab] OR postnat*[tiab] OR kid[tiab] OR kids[tiab] OR boy*[tiab] OR girl*[tiab] OR preschool*[tiab] OR kindergar*[tiab] OR prepuberty*[tiab] OR prepubescen*[tiab] OR juvenil*[tiab] OR youth*[tiab] OR puber*[tiab] OR pubescen*[tiab] OR schoolchild*[tiab] OR highschool*[tiab] OR under-aged*[tiab] OR underage[tiab] OR teen*[tiab] OR adolescen*[tiab])
("Parents"[Mesh] OR "Legal Guardians"[Mesh] OR "Caregivers"[Mesh] OR "Decision Making"[Mesh] OR "Judicial Role"[Mesh] OR "Mental Competency"[Mesh] OR "Comprehension"[Mesh] OR "Liability, Legal"[Mesh] OR "Personal Autonomy"[Mesh] OR "Child Welfare"[Mesh] OR "Infant Welfare"[Mesh] OR parent*[tiab] OR proxy[tiab] OR representative*[tiab] OR guardian*[tiab] OR caregiver*[tiab] OR care giver*[tiab] OR surrogate*[tiab] OR decision making*[tiab] OR capacity[tiab] OR capab*[tiab] OR competen*[tiab] OR legal-competen*[tiab] OR legally-competen*[tiab] OR matur*[tiab] OR emancipat*[tiab] OR waiv*[tiab] OR exempt*[tiab] OR autonomy[tiab])
("Biomedical Research"[Mesh] OR "Clinical Trials as Topic"[Mesh] OR "Research Subjects"[Mesh] OR trial[tiab] OR trials[tiab] OR random*[tiab] OR RCT[tiab] OR placebo[tiab] OR research*[tiab])
("Developing Countries"[Mesh] OR "Poverty"[Mesh] OR "Neglected Diseases"[Mesh] OR "Culture"[Mesh] OR "Culturally Appropriate Technology"[Mesh] OR "Global Health"[Mesh] OR "Health Resources"[Mesh] OR "Global Burden of Disease"[Mesh] OR low income*[tiab] OR low-resource*[tiab] OR resource*[tiab] OR resource-limited[tiab] OR resource-poor*[tiab] OR resource-restricted[tiab] OR developing countr*[tiab] OR global*[tiab] OR international*[tiab] OR developing world*[tiab] OR less-developed[tiab] OR less-advanced[tiab] OR poverty-related*[tiab] OR LMIC*[tiab] OR low-and-middle-income[tiab] OR angola[tiab] OR angolan[tiab] OR benin[tiab] OR botswana[tiab] OR "burkina faso"[tiab] OR "upper volta"[tiab] OR burundi[tiab] OR "côte d’ivoire"[tiab] OR "cote d’ivoire"[tiab] OR "ivory coast"[tiab] OR cameroon[tiab] OR camerun[tiab] OR kamerun[tiab] OR "central african republic"[tiab] OR chad[tiab] OR congo[tiab] OR zaire[tiab] OR djibouti[tiab] OR "equatorial guinea"[tiab] OR eritrea[tiab] OR ethiopia[tiab] OR gabon[tiab] OR gambia[tiab] OR guinea[tiab] OR "guinea bissau"[tiab] OR kenya[tiab] OR lesotho[tiab] OR liberia[tiab] OR malawi[tiab] OR mali[tiab] OR mauritania[tiab] OR mozambique[tiab] OR namibia[tiab] OR niger[tiab] OR nigeria[tiab] OR nigerian[tiab] OR rwanda[tiab] OR senegal[tiab] OR "sierra leone"[tiab] OR somalia[tiab] OR south africa[tiab] OR "south sudan"[tiab] OR sudan[tiab] OR swaziland[tiab] OR tanzania[tiab] OR togo[tiab] OR uganda[tiab] OR zambia[tiab] OR sambia[tiab] OR zimbabwe[tiab] OR rhodesia[tiab] OR "Africa South of the Sahara"[mesh]) NOT (animals[mh] NOT humans[mh])
We requested inaccessible articles from different libraries but did not contact authors. Articles and conference abstracts potentially relating to our topic, but for which a determination of eligibility was impossible without full-text access, were listed in the Supporting information (S1 Table). Books were rarely accessible and, therefore, completely excluded from the analysis. When available information on a book (accessible or inaccessible) suggested that it might relate to our search, the book was also listed in the Supporting information (S1 Table).
We did not limit our review to a particular study type and searched for any publication containing information about IC by minor parents in paediatric CTs conducted in SSA.
Eligibility criteria and screening
We exported all search results to a reference management software (Endnote X7). After removing duplicates, we created an MS Excel table capturing selected information from the extracted literature (Author, Year, Journal/Publisher, Title, Abstract, Keywords, ISBN/ISSN, DOI, and URL). Two independent reviewers (ADP and DOB) received a copy of the excel sheet and first screened articles based on title and abstract according to predefined eligibility criteria (Box 2).
Box 2. Eligibility criteria
Including any type of study, if relating to all of the following four key elements:
- Informed consent procedure (proxy decision-maker, autonomous consent, assent, preterm consent)
- Clinical trials (drug trials, vaccine trials, diagnostic trials, medical device trials, surgical trials, emergency research trials, nutritional supplementation trials)
- Children as
- Participants (neonates, infants, toddlers, small children) with the age of 0.0–4.9 years
- Minor parents (adolescents, teenagers, mature minors, emancipated minors) with the age of 12.0–17.9 years
- Sub-Saharan Africa (or global or international relevance, including sub-Saharan Africa)
Excluding any type of study, if relating to:
- Children with the age of 5.0–11.9 years
- Vulnerable participants in the broader sense (individuals with disabilities, geriatric subjects, ethnic minorities, migrants, etc.)
- Developed countries only
- Informed consent procedure in other than clinical trials:
- Observational studies (with and without blood samples), quality of life studies, preventive interventions (health care/health behaviour/immunisation)
- Reproductive health care (HIV testing, abortion, fertilisation, contraception, adoption, pregnancy, circumcision/sterilisation, etc.)
- Biobanking, organ donation, blood transfusion
- Genetic testing, new-born screening
- Diverse treatments
- Euthanasia/end-of-life decision-making
- Surgery (as treatment)
- Emergency treatment/treatment of serious illnesses
- Nutritional studies, if only addressing natural behaviour, such as breastfeeding
- If it is a study report using blood samples from a primary clinical trial
- Other informed consent topics, such as addressing exclusively:
- Informed consent understanding
- Informed consent return rates
- Informed consent confidentiality issues
- Other language than English and French
When eligibility was unclear based on title and abstract, available full-texts were screened. The interrater reliability was moderate (Cohen’s Kappa κ = 0.47) for the initial screening and substantial (Cohen’s Kappa κ = 0.71) for the update search screening . Disagreements between reviewers were mostly systematic and were all resolved in several rounds of discussion. One reviewer (ADP) performed the full-text assessment and a second reviewer (DOB) verified a random sample of 10%. Included papers’ full-text was screened systematically looking for minor parents using pre-defined search terms (Box 3).
Box 3. Screening strategy
Full-text screening 1
In case of missing key information after the title and abstract screening:
- Screen/Read pre-defined text sections (abstract, consent section, method section, and conclusion) and check if the key elements are addressed.
- Search for information about the key elements using the following pre-defined search terms:
- “consent” OR “assent” OR “permi*”
- “trial” OR “research”
- “child*” OR “ped*” OR “paed*” OR “minor” OR “infant” OR “adolescent” OR “teen” OR “matur*” OR “parent” OR “mother” OR “father” OR “guardian” OR “repr*”
- “inter*” OR “global” OR “countr” OR “develop*” OR “income” OR “resource”
Full-text screening 2
For all included papers after the title, abstract and full-text screening 1:
- Screen/Read pre-defined text sections (abstract, consent section, method section, and conclusions) and check if the topic of minor parents of paediatric clinical trial participants is addressed.
- Search for information about minor parents of paediatric clinical trial participants using the following pre-defined search terms:
- “prox*” OR “surr*”
- “consent” OR “assent”
- “child” OR “adol*” OR “minor” OR “teen” OR “age”
- “major” OR “eman*” OR “marr*”
- “parent” OR “mother” OR “father”
- “capa*” OR “compe*”
Data extraction and analysis
For the included articles, we extracted characteristic information on study type and procedures, country, health conditions, and the medical interventions addressed. We performed a descriptive and qualitative framework analysis using MAXQDA (VERBI GmbH) and MS Excel .
Critical appraisal of studies
Due to the information and study types identified in this review, no conventional assessment of bias risk or quality appraisal was applicable. We addressed the quality of the information descriptively in the results by reviewing the source and comprehensiveness of the implemented and recommended IC approaches, and did not exclude articles based on type or quality.
We initially identified 3346 articles from the literature search (Fig 1). After removing duplicates (n = 414), we screened the titles and abstracts of 2932 articles, and when eligibility remained unclear, we screened the full-text. 2501 articles were excluded, and the full-text of 431 was assessed, resulting in 9 articles included in the analysis. Our search update found 1450 additional articles from which seven were eligible, amounting to a total of 16 articles. The reasons for exclusion were: out of scope, emancipated/mature minors consenting for themselves, not their children, duplicates, languages other than English and French, master theses, PowerPoint presentations, books, and non-accessible full-texts of conference abstracts and papers.
aThe total number comes from three combined Google Scholar searches. bOut of scope: not addressing informed consent, not addressing SSA, not addressing children < 5, not addressing clinical trials, not addressing minor parents, not clear if addressing minor parents. cA list of these books/papers/conference abstracts can be found in the Supporting information (S1 Table). dIf information about the key elements of the search lacked in the abstract or title, articles’ full text was also screened using keywords (Box 3). eFull-text assessment was done based on a secondary screening using keywords relating specifically to minor parents (Box 3).
The 16 identified articles included various study types (Table 1) categorised into: case studies (n = 4) [22–25], one of which included a review , reviews of national legislations and ethical discussions (n = 4) [26–29], reviews of IC challenges (n = 3) [30–32], meeting/workshop reports (n = 3) [33–35], and mixed-methods research (n = 2) [36, 37]. Nine studies addressed six particular SSA countries (Senegal, Côte d’Ivoire, Kenya, Botswana, South Africa, and Uganda), while the others related to SSA, low- and middle-income countries, or global CTs in general. Infectious diseases were the most prevalent health conditions, and vaccines were the most frequently discussed medical intervention. Five articles were secondary publications of CT experiences [22–25, 36] and described the IC approach for children with minor parents applied in specific CTs [38–42]. Five further articles discussed the national legislation concerning IC requirements, including in the case of minor parents [26–29, 37]. The remaining articles mentioned IC by minor parents among several ethical challenges faced in clinical research conducted in developing countries [30–35].
We systematically extracted information on minor parents according to six themes: The frequency and age of these parents, the IC approach and the related references, IC challenges, and recommendations affecting the IC approach (Table 2).
Three of the articles relating to specific CTs mentioned explicitly the number of children with minor parents ranging from 1.4 to 4.1% [22, 24, 25]. The legal age of majority was 18 in most countries, except for Côte d’Ivoire where it was 21 (Botswana and South Africa had recently changed from 21 to 18) [47, 54]. One article highlighted that the legal age of majority might range from 14 to 21 globally .
In five articles, minor parents were allowed to consent for research participation of their children [22, 25, 31, 34, 35]. In four articles, consent by minor parents was denied [23, 24, 26, 37]. One of these articles reported that researchers first allowed minor parents to consent for the CT, but later reconsidered their procedure, as the ethics committee changed its policy during the course of the CT . Three other articles proposed conditional approaches to consent by minor parents, e.g., depending on the research risk or the marital status of the mothers [27–29], and two more articles simply acknowledged that the case of minor parents is possible and may pose challenges [32, 33]. One article involved a CT including children of minor parents, however, it did not report any details on the IC approach .
A majority (n = 11) of articles addressed challenges in designing an appropriate IC approach for CTs involving children with minor parents [22–24, 28, 29, 31–35, 37]. Most of these articles highlighted a lack of or inconsistency in local laws and guidance on the rights of minors in relation to clinical research [23, 24, 28, 29, 31, 32, 37]. A further challenge addressed in two older articles was a lack of local ethical review, as no local ethics committee existed at that time [22, 25]. Hence, one study was only reviewed by a foreign ethics committee and IRB , while the other was additionally submitted to the local ministry of health . In the latter study, researchers experienced challenges when asking minor mothers to provide formal consent, as families viewed these mothers as immature; this resulted in involving the grandparents or fathers in the decision-making . Two further articles addressed another challenge posed by a South African law reform restricting consent for children to adult parents and legal guardians, excluding other caregivers [26, 27]. This reform resulted in a specific barrier to recruiting children whose parents were minors and had lost the support of their parents .
Several articles provided specific references to IC approaches proposed for children with minor parents, such as four national laws on children’s rights [43–46], one national research regulation , one national research guideline , and four position papers on children’s rights in research [49–52]. One source referred to a legal review inaccessible for our study . Based on these references, none of the applied or proposed IC approaches reported in the initial articles could be confirmed as mandatory or an established standard of practice. Some references mentioned conditions for adolescents’ autonomous consent for their own research participation without explicitly invoking their children [43, 48, 51, 52]. The only reference directly referring to consent approaches for children of minor parents was the South African Children’s Act (and its predecessor, the South African Child Care Act) [45, 46]. However, none of the national laws on children’s rights (including the South African ones) addressed clinical research [43–46].
Overall, only two articles provided comprehensive recommendations on IC for CT participation of children with minor parents [24, 28], as presented in detail in Table 2. One of these articles based the IC approach on a review and discussion of national legislation of children’s rights . The other one addressed ethical considerations for the development of an IC approach for children of minor parents based on a review of relevant literature and guidelines, including consensus by an international expert panel .
Other articles offered general recommendations concerning IC implementation in SSA [23, 25–27, 30–32, 34, 35, 37]. These involved a consideration for the local context and norms [23, 27, 31, 32, 34], the capacity of local ethics committees and regulatory authorities [30, 31], the availability of context-adapted research guidelines and laws [26, 37], and the representation of target populations in research advisory boards .
Finally, we provide an overview of additional challenges for IC in research in SSA (Table 3) mentioned across the 16 articles. These are general considerations, which may benefit the development of an appropriate IC approach for CTs involving children with minor parents in resource-limited settings (RLS).
This systematic literature review presents evidence on CT recruitment and IC practice for children with minor parents in SSA. Overall, our results show that researchers experienced the need to find a solution concerning IC when enrolling children with minor parents and were challenged by the lack of a specific regulation or guidance.
A similar number of articles accepted or denied minor parents providing independent IC for their children and both approaches involved specific uncertainties. Becoming an emancipated or “mature minor” was the key argument promoting independent consent by minor parents [31, 34, 35]. When considering the referenced literature, however, we found this approach to lack legislative clarity and generalisability [43, 48, 51, 52]. First, the emancipation or “mature minor” status did not explicitly relate to clinical trials with children of minors. Instead, it related either to autonomous consent by adolescents for their own research participation or to medical care rather than research. Further, the conditions to reach emancipated or “mature minor” status, through marriage, parenthood, etc., vary across countries, as do the rights ensuing from the respective status. In N’Goran et al., minor parents could be considered emancipated when married; however, they could not provide consent for their children’s research participation . Lema et al. mention that minor parents may have the authority to consent for their children’s medical care while not being considered mature enough to consent to their own research participation autonomously . A recent position paper by the American Academy of Pediatrics confirms this ambiguity: All (US) states accept medical decision-making by minor parents for their children, without necessarily acknowledging minor parents as emancipated or mature to authorise their own medical care . Another perspective is yet added by the Guidelines for Conduct of Clinical Trials in Kenya, which consider minor parents directly as “emancipated minors” able to consent for themselves and being explicitly allowed to consent to CT participation of their children . These examples indicate that the legal status alone does not always equate to an adolescent’s capacity for decision-making and emphasise the need for clear conditions establishing minor parents’ competence to consent for themselves and their children.
In studies where minor parents were not considered emancipated or competent to consent independently for their children, consent was provided by an adult proxy [23, 24, 37], which included the other parent (if an adult), grandparents, or legally authorised representatives or guardians. This approach raises the problem of identifying appropriate decision-makers, a known issue for paediatric research in the SSA context . It involves the additional consideration of gender dynamics, hierarchical family structures (e.g., matrilineal, or patrilineal), or shared versus individual decision-making within the family or community [30, 32, 34, 35, 37]. Also, formal identification of individuals accompanying children may pose problems, as people in RLS may lack birth certificates or identity documents [23, 26]. In one study, the village chief was therefore asked to confirm identities . Ignoring local norms may affect the IC validity and, hence, the protection of CT participants and could result in a recruitment failure or subsequent consent withdrawal . Therefore, community involvement in the development and approval of the IC approach before CT implementation is essential to address specific scenarios upfront and find practical and acceptable solutions.
CT participation risks may further influence the IC approach. Risks play a role in deciding whether one or both parents have to provide consent and at what age a person is capable of consenting. Earlier interpretations of South African laws restricted non-therapeutic trials bearing more than a negligible risk to participants above the age of 21 . The research area may also have an influence, and in certain fields, such as HIV transmission prevention, additional consent by grandparents may pose a barrier to research participation of minor parents and their children, due to privacy reasons and fear of stigmatisation . Hence, individual consent by minor parents alone might be encouraged to improve access to such research. Independent consent by minor mothers might also be encouraged in cases when children are typically accompanied by their mothers and health facilities are difficult to access [9, 22]. Requiring these mothers, when competent, to always consult their husbands or families before being able to consent, may be disruptive to the recruitment of these children. At the time when communities are informed about the CT, however, willingness to participate in the CT can also be discussed in advance, particularly in families where such a situation is expected.
In the case of consent by adult proxies, included studies lacked information on the extent of minor parents’ involvement in the IC process. Only one article mentioned explicitly how minor parents were consulted in parallel with the consent of an adult. It proposed that minor parents could first provide a co-consent and then re-consent independently when reaching majority during the CT . This approach is supported by acknowledgements across literature in the past decade that minors should be involved in decision-making according to their developmental capacity [55, 56].
We further detected limited transparency for reported IC procedures for children of minor parents in primary CT publications. This is emphasised by the fact that we did not identify any primary CT publication addressing minor parents in our results. Five included articles, which were secondary studies on CT experiences, however, referenced primary CT publications. We reviewed these publications, and in three of them, we could not find any indication of the parents’ ages, and the IC statement was limited as well [38, 41, 42]. Minor parents’ involvement was only evident in the secondary studies’ publications [22, 25, 36]. One of the three primary CT publications stated that “oral IC was obtained from all mothers of the study infants”, and more information on minor mothers’, parents’ and husbands’ participation in decision-making was reported as significant only in the secondary study . The second primary CT publication stated “those whose parents agreed were vaccinated” without mentioning that some of the consenting parents were minors . The third primary CT publication provided the following statement: “written IC was obtained from the children’s parents or guardians” . It is debatable how much more information beyond such blanket statements should researchers report in primary CT publications to effectively describe the IC procedures applied, considering typical word limitations in publishing and the relevance of the topic in relation to other information provided in CT publications.
Strengths and limitations
This review has some limitations. Information about minor parents was scarce and typically included as a tangential thought only. Hence, we additionally developed a full-text screening strategy to increase our screening efficiency (Box 3). This strategy may have led to overlooking some relevant terms and articles limited to these terms. We identified many articles, representing secondary studies based on primary CT publications, which sometimes included minor mothers. Most of these primary CT reports, however, did not figure in our search results independently, probably due to lacking specific links to standardised keywords. As many of those primary CT publications also lacked a reference, we systematically excluded them, except when including the secondary studies, then we also considered the information provided in the primary CT publications, if accessible.
Further, we used Google Scholar to access also grey literature, such as dissertations, organisation reports, government publications, etc. The translated search, however, yielded more articles than Google Scholar was able to display, as it is limited to a maximum of 1000 articles . We decided to include all accessible articles and ran two additional, very limited searches on Google Scholar to maximise the output of relevant publications under the given circumstances. This also explains why the number of articles detected on Google Scholar, as presented in the flow chart is larger than 1000. Also, we did not systematically search the supplementary files of articles, which may have contained information on minor parents.
Moreover, the review clarifies that information about minor parents is typically published in secondary studies and in qualitative reports on CT experiences, and not in primary CT publications. This suggested that IC information required in CT publications might be too brief to allow an adequate picture of ethical issues faced during the CT conduct and IC issues may be preferably addressed elsewhere (e.g., protocol, ethics committee review, supplementary files, or secondary article on CT challenges). Hence, future research could focus on identifying more details from screening CT protocols involving infants in SSA published in CT registries, as these may better reflect ethical considerations. However, technicalities on the identification of decision-makers may not be addressed in protocols either and may only become evident based on CT management manuals, standard operating procedures, or IC trackers, which are inaccessible to the public, if not specifically self-reported or requested.
Despite available information on the subject being rare and the related challenges to detect such information, we consider this review valuable in supporting future CT conduct. With the help of an elaborate search strategy and the unlimited consideration of various study types, we present a first overview of IC approaches applied for CT involving children with minor parents in SSA. We thereby raise evidence on the challenges faced in these situations and point to evidence-based solutions.
This review highlights that there is no one-size-fits-all approach in handling IC in CTs with children of minor parents in SSA. The status of guidance is variable across countries and, frequently, clear conditions establishing minor parents’ competence to consent for themselves and their children are missing. Nevertheless, challenges can be mitigated through increasing awareness about the IC approach and appropriate planning before CT implementation. Thereby, the following should be considered: 1) Is a local law available regarding emancipation, or the “mature minor” status? 2) Does the law define whether and under what conditions minors are considered competent to consent on behalf of their children in a CT? Local laws often lack in the context of research, but when regulations on medical care exist, their provisions could also apply to research (see example by Strode and Slack (2011)), 3) Is there an existing official approach (e.g. in a national CT guideline or regulation, institutional guidance)? Did important stakeholders, including the ethics committee and the community approve the approach? Are the ministry of health, regulatory authorities, and local leaders aware of it? 4) Is the approach applicable under the individual circumstances of the CT, considering the local social and cultural context and study related risks? 5) When developing a new approach, have specific ethical considerations and practical challenges been addressed (see example provided by Ott et.al 2018 and Table 3 of this article)? 6) Was the approach described or referred to in the study protocol and were possible practical challenges mitigated? 7) Was the possibility of minor parents addressed in the CT publication? We argue that special IC situations should be described in publications and, if this is not possible due to restrictions of word count, in an appendix to the publication.
We further conclude that international CT guidelines, such as the ICH Clinical Investigation of Medicinal Products in the Pediatric Population E11 (R1), should be amended to include a general statement on the variability of IC for children of minor parents, e.g. “National guidance on the IC for children must be adhered to; where they are missing or local conventions deviate from such guidance, the process must be described in the study protocol and be mentioned in scientific publications”.
Our acknowledgements go to Eric Huber (Department of Medicine, Swiss Tropical and Public Health Institute and University of Basel, Basel, Switzerland) who facilitated a major part of the funding (EDCTP) for this study in the framework of the PZQ4PSAC project. Without him, the realisation of this study would not have been possible. We further thank the medical university librarians for their support in reviewing the search terms and search strategy, as well as carrying out the search update: Heidrun Janka and Dr. Hannah Ewald (University Medical Library, University of Basel, Basel, Switzerland). We are also grateful to Dr. Claire Leonie Ward (Institute for Biomedical Ethics at the University of Basel, Basel, Switzerland) for initial expert advice on research ethics in the sub-Saharan African context.
- 1. International Ethical Guidelines for Health-related Research Involving Humans. Fourth Edition. Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016.
- 2. UNICEF. Under-five mortality. 2019 [cited 2019 Dec 17]. https://data.unicef.org/topic/child-survival/under-five-mortality/
- 3. GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1684–735.
- 4. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.
- 5. Lang TA, White NJ, Tran HT, Farrar JJ, Day NP, Fitzpatrick R, et al. Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis. 2010;4(6):e619. pmid:20614013
- 6. Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS. Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry. Pediatrics. 2012;130(5):e1269–e77.
- 7. Patton GC, Sawyer SM, Santelli JS, Ross DA, Afifi R, Allen NB, et al. Our future: a Lancet commission on adolescent health and wellbeing. Lancet. 2016;387(10036):2423–78. pmid:27174304
- 8. ICH Harmonized Guideline. Addendum to ICH E11: Clinical Investigation of Medicinal Products in the Pediatric Population E11(R1). International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; 2017.
- 9. Nuffield Council on Bioethics. Children and clinical research: ethical issues. London: Nuffield Council on Bioethics; 2015.
- 10. MRC Ethics Guide: Medical research involving children. London: Medical Research Council; 2004.
- 11. American Academy of Pediatrics. Committee on Bioethics. Informed Consent in Decision-Making in Pediatric Practice. Pediatrics. 2016;138(2):e20161484.
- 12. Ministry of Health. Pharmacy and Poisons Board. Guidelines for Conduct of Clinical Trials in Kenya. Rev. No. 1. Nairobi, Kenya; 2016 [cited 2020 Jun 11]. https://pharmacyboardkenya.org/clinical-trials.
- 13. HHS. International Compilation of Human Research Standards: U.S. Department of Health & Human Services; 2020 [cited 2020 Jun 18]. https://www.hhs.gov/ohrp/sites/default/files/2020-international-compilation-of-human-research-standards.pdf
- 14. Devasenapathy N, Singh K, Prabhakaran D. Conduct of clinical trials in developing countries: a perspective. Curr Opin Cardiol. 2009;24(4):295–300. pmid:19444095
- 15. Caldwell PH, Dans L, de Vries MC, Newman J, Sammons H, Spriggs M, et al. Standard 1: consent and recruitment. Pediatrics. 2012;129(Supplement 3):S118–S23.
- 16. Klassen TP, Hartling L, Hamm M, van der Lee JH, Ursum J, Offringa M. StaR Child Health: an initiative for RCTs in children. Lancet. 2009;374(9698):1310–2. pmid:19837237
- 17. Frakking FN, van der Lee JH, Klassen TP, Offringa M. Survey of current guidance for child health clinical trials. The StaR Child Health project: standards for research in children. WHO Progress reports—Standards in clinical trials. 2009 [cited 2020 Jan 20]. https://www.who.int/childmedicines/publications/GUIDANCECHILDHEALTH.pdf
- 18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. pmid:19621072
- 19. PROSPERO. International prospective register of systematic reviews [cited 2019 Dec 12]. https://www.crd.york.ac.uk/prospero/
- 20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74. pmid:843571
- 21. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117. pmid:24047204
- 22. Diallo A, Ly C, Simondon F, Simondon KB. Consentement éclairé pour la recherche biomédicale dans les pays en développement: procédures et attitudes parentales dans un essai randomisé de supplémentation alimentaire de nourrissons sénégalais. J Int Bioéthique. 2003;14(1–2):195–207.
- 23. N’Goran E, Aka NAD, Ouattara M, Huber E, Bezuidenhout D, Kourany-Lefoll E. Challenges and Lessons From Conducting A Paediatric Clinical Trial in Sub-Saharan Africa: The Case of the Praziquantel Oral Dispersible Tablets Phase II Study in Côte d’Ivoire. Adv Parasitol. 2019;103:75–89.
- 24. Ott MA, Crawley FP, Saez-Llorens X, Owusu-Agyei S, Neubauer D, Dubin G, et al. Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials. Paediatr Drugs. 2018;20(3):215–22. pmid:29476333
- 25. Preziosi MP, Yam A, Ndiaye M, Simaga A, Simondon F, Wassilak SG. Practical experiences in obtaining informed consent for a vaccine trial in rural Africa. N Engl J Med. 1997;336(5):370–3. pmid:9011793
- 26. Slack CM, Strode A. But is this really the ‘parent’or ‘guardian’? Practical strategies for consent to child research in South Africa. S Afr J Bioeth Law. 2016;9(1):35–8.
- 27. Strode A, Richter M, Wallace M, Toohey J, Technau K. Failing the vulnerable: Three new consent norms that will undermine health research with children. South Afr J HIV Med. 2014;15(2):46–9.
- 28. Strode AE, Slack CM. Using the concept of ‘parental responsibilities and rights’ to identify adults able to provide proxy consent to child research in South Africa. S Afr J Bioeth Law. 2011;4(2):69–73.
- 29. van Wyk C. The participation of minors in preventive HIV research trials in South Africa: Legal and human rights considerations. Med Law. 2003;22(4):589–98. pmid:15074750
- 30. Colom M, Rohloff P. Cultural considerations for informed consent in paediatric research in low/middle-income countries: a scoping review. BMJ Paediatr Open. 2018;2(1):e000298. pmid:30613801
- 31. Idoko O, Afolabi MO, Ogutu B, Ota M. Vaccine trials in Africa: Impact and challenges. iConcept Journal of Emerging Issues in Medical Diagnosis and Treatment. 2016;5(1).
- 32. Lema VM, Mbondo M, Kamau EN. Informed consent for clinical trials: a review. East Afr Med J. 2009;86(3):133–42. pmid:19702101
- 33. Mamotte N, Wassenaar D, Koen J, Essack Z. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme’s Ethics, Law and Human Rights Collaborating Centre consultation, 10–11 February 2009, Durban, South Africa. BMC Med Ethics. 2010;11:3.
- 34. Ravinetto R, Tinto H, Rouamba N, Talisuna A, Adoke Y, Kadima Ebeja A, et al. Health research: The challenges related to ethical review and informed consent in developing countries. Giornale Italiano di Medicina Tropicale. 2010;15(1–4):15–20.
- 35. van Hoog S. Piecing Together the Prevention Puzzle. Recognizing HIV vaccines as a key component of a comprehensive prevention strategy for young people. Global Youth Coalition on HIV/AIDS; 2013.
- 36. Angwenyi V, Kamuya D, Mwachiro D, Kalama B, Marsh V, Njuguna P, et al. Complex realities: Community engagement for a paediatric randomized controlled malaria vaccine trial in Kilifi, Kenya. Trials. 2014;15(1):65.
- 37. Kasule M. A model for obtaining parental informed consent for HIV clinical trials research with pediatric patients. Doctoral Thesis, University of the Western Cape. 2013. https://etd.uwc.ac.za/xmlui/bitstream/handle/11394/3961/Kasule_PHD_2013.pdf?sequence=1&isAllowed=y
- 38. Simondon KB, Gartner A, Berger J, Cornu A, Massamba JP, San Miguel JL, et al. Effect of early, short-term supplementation on weight and linear growth of 4–7-mo-old infants in developing countries: a four-country randomized trial. Am J Clin Nutr. 1996;64(4):537–45.
- 39. An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni). 2016 [cited 2019 Dec 12]. https://clinicaltrials.gov/ct2/show/NCT02806232
- 40. Tregnaghi MW, Saez-Llorens X, Lopez P, Abate H, Smith E, Posleman A, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. PLoS Med. 2014;11(6):e1001657. pmid:24892763
- 41. Simondon F, Yam A, Gagnepain JY, Wassilak S, Danve B, Cadoz M. Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants. Eur J Clin Microbiol Infect Dis. 1996;15(12):927–32. pmid:9031875
- 42. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, et al. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med. 2011;365(20):1863–75. pmid:22007715
- 43. Loi no 70–483 du 3 août 1970 sur la minorité. Côte d’Ivoire [cited 2019 Dec 12]. https://elearning.trree.org/pluginfile.php/34816/mod_folder/content/0/08_Loi_sur_la_minorite.pdf?forcedownload=1
- 44. Parliament of Botswana. Children’s Act 2009. Botswana [cited 2019 Dec 12]. http://jafbase.fr/docAfrique/Botswana/Children%20act.pdf
- 45. Department of Social Development (Western Cape Government). Child Care Act 74 of 1983. South Africa [cited 2019 Dec 12]. https://www.westerncape.gov.za/legislation/child-care-act-74-1983-0
- 46. Parliament of the Republic of South Africa. Children’s Act 38 of 2005. South Africa [cited 2019 Dec 12]. http://www.justice.gov.za/legislation/acts/2005-038%20childrensact.pdf
- 47. Government Notice. Republic of South Africa. Department of Health. No. R. 378, National Health Act, 2003 (Act No. 61 of 2003), Regulations Relating to Research with Human Subjects (published for public comment). Pretoria, Republic of South Africa: Government Gazette No. 36508; 2013 [cited 2019 Dec 12]. http://www.samed.org.za/Filemanager/userfiles/News/Regulation%20Gazette%20National%20Health%20Act%20Regulations.pdf
- 48. Guidelines of the Uganda National Council for Sciences and Technology. Uganda; 2014 [cited 2019 Dec 12]. https://www.uncst.go.ug/
- 49. Maundeni T, Levers LL. Concerns about child subject research in Botswana: a call for establishing structures and guidelines that protect children. Afr. Sociol. Rev. 2005; 9(2):153–67.
- 50. Cluver L, Orkin M, Boyes M, Gardner F, Meinck F. Transactional sex amongst AIDS-orphaned and AIDS-affected adolescents predicted by abuse and extreme poverty. J Acquir Immune Defic Syndr. 2011;58(3):336–43. pmid:21857361
- 51. Santelli JS, Smith Rogers A, Rosenfeld WD, DuRant RH, Dubler N, Morreale M, et al. Guidelines for adolescent health research. A position paper of the Society for Adolescent Medicine. J Adolesc Health. 2003;33(5):396–409. pmid:14596961
- 52. McClure CA, Gray G, Rybczyk GK, Wright PF. Challenges to conducting HIV preventative vaccine trials with adolescents. J Acquir Immune Defic Syndr. 2004;36(2):726–33. pmid:15167292
- 53. Heaton J. The South African Law of Persons. Durban: Lexis Nexis Butterworths; 2009.
- 54. Republic of Botswana. Government portal. Maturity age reduced to 18. 2010 [cited 2019 Dec 12]. http://www.gov.bw/en/News/Majority-age-reduced-to-18-years-of-age-/
- 55. Marsh V, Mwangome N, Jao I, Wright K, Molyneux S, Davies A. Who should decide about children’s and adolescents’ participation in health research? The views of children and adults in rural Kenya. BMC Med Ethics. 2019;20(1):41. pmid:31200697
- 56. Mystakidou K, Panagiotou I, Katsaragakis S, Tsilika E, Parpa E. Ethical and practical challenges in implementing informed consent in HIV/AIDS clinical trials in developing or resource-limited countries. SAHARA J. 2009;6(2):46–57. pmid:19936406
- 57. Haddaway NR, Collins AM, Coughlin D, Kirk S. The Role of Google Scholar in Evidence Reviews and Its Applicability to Grey Literature Searching. PloS One. 2015;10(9):e0138237. pmid:26379270